Improving COVID-19 diagnostics in low-resource settings
Official title: Basic Research for Diagnostics and Surveillance in Lower Resource Environments
Funded at Foundation for Applied Molecular Evolutn · NIH-10895463 · Data updated 2026-11-12
This study is looking at how DNA and RNA work together to make better tests for COVID-19 and other germs, so that patients can get quicker and more accurate results, especially in places that might not have a lot of resources.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Foundation for Applied Molecular Evolutn NIH-funded |
| Lab location | 1 site (Alachua, United States) |
| Project start | August 12, 2021 |
| Project end | July 31, 2025 |
| Funding year | 2024 |
| Award (this year) | $671,088 |
| NIH project number | 5R01AI135146-04 |
| Project ID | NIH-10895463 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals in low-resource settings who require reliable COVID-19 testing.
✕Less likely to help
Patients in high-resource environments with access to advanced diagnostic technologies may not benefit from this research.
What this research studies
This research focuses on enhancing the understanding of DNA and RNA pairing and mispairing to improve diagnostic tests for COVID-19 and other pathogens. By investigating the limitations of current multiplexed PCR techniques, the research aims to identify why existing methods fail when adding multiple targets. The goal is to develop more reliable diagnostic tools that can quickly adapt to emerging pathogens, which is crucial for timely public health responses. Patients may benefit from more accurate and accessible testing options in lower-resource environments.
Why it matters
Potential benefit: If successful, this research could lead to more effective and adaptable COVID-19 diagnostic tests, improving patient care and public health responses.
How similar studies have gone: While there have been advancements in diagnostics, this research addresses specific challenges in multiplexed PCR that have not been fully resolved, making it a novel approach.
Where this research is happening
-
Foundation for Applied Molecular Evolutn
Alachua, United States Active
Researchers
- Principal investigator: Benner, Steven a — Foundation for Applied Molecular Evolutn
- Study coordinator: Benner, Steven a
Related research
Other NIH-funded projects on the same topics.
-
Tau and p-Tau blood biomarkers to predict outcomes after complicated mild traumatic brain injury
A research team is validating Tau and phosphorylated Tau as blood biomarkers to help predict which patients with complicated mild TBI will have poorer outcomes.
-
Custom molecules that destroy cancer proteins
Researchers are building synthetic molecules that stick to and cut cancer-related proteins to speed up cancer research and future treatments.
-
Creating molecules that can target and destroy cancer proteins
This study is working on new tools that can help target and break down proteins related to cancer, with the goal of making cancer treatments faster and more affordable for patients like you.
-
Creating stable antibody replacements on demand
This study is exploring a new kind of antibody replacement called Spiegel ERAbodies, which can be made quickly and easily to help scientists better understand diseases and improve treatments, making the process faster and more affordable.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.